One-Tooth One-Time (1T1T) A Straightforward Approach to Replace Missing Teeth in the Posterior Region: a Case Series
NCT ID: NCT02898311
Last Updated: 2019-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
INTERVENTIONAL
2016-07-31
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Complementary ex vivo analyses will be performed to evaluate the wear of restorations. The time and cost benefit of the presented digital workflow, as patient centered outcomes will also be evaluated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
One-abutment One-time for Immediate Restoration Procedure in the Esthetic Zone
NCT04139512
DAMP1: The 1T1T Concept Versus Conventional Implant Loading Protocol
NCT04045574
Two-unit Cantilever Implant Prostheses Made of Monolithic Zirconia or PFM
NCT04713800
One-piece and Two-piece Zirconia Abutments in Single Implant Crowns in Esthetic Region
NCT05583123
Minimally Invasive Treatment of Worn Dentition With Innovative CAD-CAM Composites
NCT02828696
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
immediate loading of posterior implants with chairside CAD-CAM composite crown
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Present with no contra indication against oral surgical interventions
* The tooth at the implant site(s) must have been extracted or lost at least 12 weeks before the date of implantation.
* At least 8 mm of bone in the vertical dimension
* At least 6 mm of bone in the bucco-lingual dimension.
* No need for bone augmentation procedure in any of the dimensions
* Full mouth plaque score (FMPI) lower or equal than 25%
Exclusion Criteria
* Medical conditions requiring prolonged use of steroids
* Use of Bisphosphonate intravenously or more then ˃ 3 years of oral use
* Infection (local or systemic) - patient with gingivitis or active local infection will undergo a medical treatment prior to his entrance to the study, each individual will be evaluated prior to study procedure for suitability, in case of systemic infection the evaluation will be based on medical anamneses, and if necessary will be referred to relevant medical tests.
* Current pregnancy or breastfeeding women
* Alcoholism or chronically drug abuse
* Immunocompromised patients
* Uncontrolled Diabetes
* Smokers
* Prisoners
* Conditions or circumstances, in the opinion of the investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance, or unreliability.
* Sites treated with socket preservation techniques
* Untreated local inflammation
* Mucosal diseases or oral lesions
* History of local irradiation therapy in Head-Neck area
* Persistent intraoral infection (periodontitis, caries, …)
* Patients inadequate oral hygiene or unmotivated for normal home care.
* Removable prosthesis as an antagonist of the teeth to be replaced or absence of antagonistic teeth
* Severe bruxism or parafunctions
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Liege
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mainjot Amélie
Associate professor- Head of Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Liege University Hospital Center of Liege
Liège, , Belgium
University Hospital Center of Liège
Liège, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TT001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.